BioNexus Gene Lab
BGLC
$0.59
Share price
-0.84%
Change (1 day)
136.00%
Change (1 year)
Categories
P/S ratio for BioNexus Gene Lab (BGLC)
P/S ratio as of May 2024 (TTM): 1.07
According to BioNexus Gene Lab's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.06685. At the end of 2023 the company had a P/S ratio of 1.49.
P/S ratio history for BioNexus Gene Lab from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.49 | -90.14% |
| 2022 | 15.1 | -44.67% |
| 2021 | 27.3 | 115.13% |
| 2020 | 12.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |